China launches first insurance policy for invasive brain-computer interface surgery

PICC Property and Casualty, a major state-owned insurer, unveiled a pioneering insurance scheme that covers the invasive surgery required to implant brain-computer interface devices, partnering with a public hospital affiliated with Zhejiang University School of Medicine in Hangzhou. The policy is part of a broader governmental push, with Zhejiang province pledging additional financing and encouraging BCI firms to list publicly.

Market reaction was immediate, as Hong Kong-listed BCI companies, including Shanghai Heartcare Medical Technology and BrainAurora Medical Technology, posted modest gains. Chinese clinicians have conducted at least a dozen human trials, noting a 61-year-old paraplegic regained leg movement within days, yet cautioned that multi-year safety evidence is still lacking. The development contrasts with Elon Musk’s Neuralink ambitions, which he describes as “Jesus-level” technology aimed at treating chronic conditions. Authorities see the insurance coverage as a catalyst to accelerate commercial adoption of BCI technology in China.